Image de couverture de livre

Preclinical evidence using synthetic compounds and natural products indicates that AMPK represents a potential pharmacological target for the therapy of pulmonary diseases

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Chao Yang, Limor Rubin, Xiyong Yu, Philip Lazarovici, Wenhua Zheng
Format:	Artículo Open Access
Publié:	Wiley 2024
Sujets:	Medicinal Research Reviews
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Rethinking therapeutic strategies of dual‐target drugs: An update on pharmacological small‐molecule compounds in cancer
par: Yiren Yang, et autres
Publié: (2024)

The antisickling agent, 5‐hydroxymethyl‐2‐furfural: Other potential pharmacological applications
par: Piyusha P. Pagare, et autres
Publié: (2024)

OGG1: An emerging multifunctional therapeutic target for the treatment of diseases caused by oxidative DNA damage
par: Yunxiao Zhong, et autres
Publié: (2024)

The menace of severe adverse events and deaths associated with viral gene therapy and its potential solution
par: Artyom Kachanov, et autres
Publié: (2024)

Bioactive atropisomers: Unraveling design strategies and synthetic routes for drug discovery
par: Shuai‐Jiang Liu, et autres
Publié: (2024)

Natural products as IL‐6 inhibitors for inflammatory diseases: Synthetic and SAR perspective
par: Dipesh S. Harmalkar, et autres
Publié: (2024)

Insights into Ganoderma fungi meroterpenoids opening a new era of racemic natural products in mushrooms
par: Jiao‐Jiao Zhang, et autres
Publié: (2024)

Advances in reversible covalent kinase inhibitors
par: Zheng Zhao, et autres
Publié: (2024)

Fluorescent imaging probes for in vivo ovarian cancer targeted detection and surgery
par: Roberta Solidoro, et autres
Publié: (2024)

Current emerging therapeutic targets and clinical investigational agents for schizophrenia: Challenges and opportunities
par: Na Ye, et autres
Publié: (2024)

CXCR4/CXCL12 axis: “old” pathway as “novel” target for anti‐inflammatory drug discovery
par: Liuxin Lu, et autres
Publié: (2024)

Emerging phosphodiesterase inhibitors for treatment of neurodegenerative diseases
par: Yu Xiang, et autres
Publié: (2024)

Pathophysiological significance and modulation of the transient receptor potential canonical 3 ion channel
par: Vijay K. Boda, et autres
Publié: (2024)

Innovative pathological network‐based multitarget approaches for Alzheimer's disease treatment
par: Paloma Mayo, et autres
Publié: (2024)

Development and therapeutic potential of GSPT1 molecular glue degraders: A medicinal chemistry perspective
par: Xiujin Chang, et autres
Publié: (2024)

Targeting lysosomal quality control as a therapeutic strategy against aging and diseases
par: Yuchen He, et autres
Publié: (2024)

Antineoplastics for treating Alzheimer's disease and dementia: Evidence from preclinical and observational studies
par: Viswanath Das, et autres
Publié: (2024)

Advances in drug design and therapeutic potential of selective or multitarget 5‐HT1A receptor ligands
par: Gianfabio Giorgioni, et autres
Publié: (2024)

Polymer nanotherapeutics: A promising approach toward microglial inhibition in neurodegenerative diseases
par: Sanaz Keshavarz Shahbaz, et autres
Publié: (2024)

Unleashing the Power of Covalent Drugs for Protein Degradation
par: Meng‐Jie Fu, et autres
Publié: (2025)

How Artificial Intelligence Assists in Overcoming Drug Resistance?
par: Ferdinand Ndikuryayo, et autres
Publié: (2025)

Estrogen deficiency‐mediated osteoimmunity in postmenopausal osteoporosis
par: Yao Yao, et autres
Publié: (2024)

Mucin O‐Glycosylation and Mucolytic Therapies in Pseudomyxoma Peritonei: Literature Review
par: Qi‐Di Zhao, et autres
Publié: (2026)

Harnessing the Power of Natural Products for Targeted Protein Degradation
par: Bo Zhu, et autres
Publié: (2025)

Danshensu Derivatives: A Series of Promising Drugs With Protective Effects Against Cardiocerebrovascular Diseases and Cancers
par: Yang Yang, et autres
Publié: (2025)

Inside Front Cover Image, Volume 44, Issue 2
par: Yu Zheng, et autres
Publié: (2024)

A Possibility of Synthetic Lethality: Wee1 Kinase as a Promising Treating Target for Cancer
par: Xin Xue, et autres
Publié: (2026)

Cutting‐Edge Therapy and Immune Escape Mechanisms in EBV‐Associated Tumors
par: Jie Wang, et autres
Publié: (2025)

Targeting ClpP Protease: Emerging Therapeutic Strategies and Small‐Molecule Modulators in Drug Discovery
par: Lihua Liu, et autres
Publié: (2026)

Canonical effects of cytokines on glomerulonephritis: A new outlook in nephrology
par: Sepideh Zununi Vahed, et autres
Publié: (2024)

A comprehensive review on the development of chiral Cu, Ni, and Zn complexes as pharmaceutical agents over the past decades: Synthesis, molecular structure and biological activity
par: Zahra Kazemi, et autres
Publié: (2024)

Tirzepatide in Metabolic Diseases: Clinical Efficacy and Safety Beyond Diabetes and Obesity
par: Shixuan Dong, et autres
Publié: (2026)

Medicinal Chemistry Strategies for the Development of CD73 Inhibitors in Cancer Immunotherapy
par: Meng Cui, et autres
Publié: (2025)

H+‐slip correlated to rotor free‐wheeling as cause of F1FO‐ATPase dysfunction in primary mitochondrial disorders
par: Salvatore Nesci, et autres
Publié: (2024)

Front Cover Image, Volume 45, Issue 4
par: Nicola Bauer, et autres
Publié: (2025)

Issue Information
Publié: (2024)

Targeting Histone H3K9 Methyltransferase G9a as a Potential Therapeutic Strategy for Neuropsychiatric Disorders
par: Malak Hajar, et autres
Publié: (2025)

Metal complexes bearing EGFR‐inhibiting ligands as promising anticancer agents
par: Xiaoyan Ma, et autres
Publié: (2024)

Compelling Evidence: A Critical Update on the Therapeutic Potential of Carbon Monoxide
par: Nicola Bauer, et autres
Publié: (2025)

Kinin B 1 and B 2 Receptors: Role in Tumor Progression and Pain Associated With Tumor and Anticancer Therapy
par: Indiara Brusco, et autres
Publié: (2025)